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Local Staging of Prostate Cancer 
with Endorectal MR Imaging:
Correlation with Histopathology
OBJECTIVE. To evaluate the accuracy of MR imaging of the prostate with an 
endorectal surface coil in determining presence, localization, volume, and local stage 
of prostate carcinoma.
SUBJECTS AND METHODS. MR images of 34 patients with biopsy-proven cancer 
were correlated retrospectively with the histologic mappings of radical prostatectomy 
specimens. The volume and number of tumor lesions on MR images were calculated 
and compared with the surgical specimens used as the gold standard. Tumor stage 
based on MR imaging was compared with the pathologic stage according to the TNM 
classification. Predictive values were calculated separately for all lesions and for the 
lesions correctly localized with MR imaging.
RESULTS. MR imaging correctly depicted the location of 67% of the tumors. Twenty 
percent of the lesions depicted by MR imaging appeared to be false-positive errors. 
The tumors that were missed were located centrally and ventrally in the prostate. 
Tumor volume as shown by MR imaging was within a 25% range of the actual tumor 
volume in 10 cases, overestimated in 16 cases, and underestimated in eight cases. 
Histopathology showed capsular penetration in 12 of 34 patients (35%) and in 14 of 52 
lesions (27%). Sensitivity, specificity, and positive predictive values were 43%, 84%, 
and 55%, respectively. Histologically, capsular penetration extended less than 1 mm 
into the periprostatic adipose tissue in seven patients. Sensitivity for capsular pene­
tration less than 1 mm was 14%. Sensitivity for capsular penetration more than 1 mm 
was 71 %. Accuracy for differentiating a pT2 from a pT3 tumor was 68%.
CONCLUSION. Results from this study indicate that the accuracy of the technique 
was not satisfactory for predicting actual tumor volume. Tumor detection and local­
ization was more accurate in the peripheral zone than in the central zone. Accuracy 
was poor for detecting capsular penetration of less than 1 mm, but accuracy was 
much better for penetration of more than 1 mm. Because recent reports suggest that 
capsular penetration of less than 1 mm does not adversely affect surgical cure, MR 
imaging still may be practical in the selection of patients for radical prostatectomy.
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The incidence of prostate cancer is increasing. The disease trails only lung cancer 
as the leading cause of death in men [1], Staging of prostate cancer is a systematic 
classification of the extent of disease based on clinical and pathologic criteria. Clini­
cal stage is used to sort patients into comparable groups for definitive therapy, 
whereas pathologic stage is important in predicting prognosis and the need for addi­
tional therapy. Curative treatment is considered possible only if the tumor is confined 
to the prostate gland (stage <T2) [2]. Therefore, differentiating between a T2 and a 
T3 tumor is clinically important. On the other hand, several reports have stated that 
patients with minimal capsular penetration have a prognosis similar to that of patients 
whose tumors are completely confined to the prostatic capsule [3,4].
Not established is what MR imaging technique results in the most accurate diag­
nosis and preoperative staging. Initially, the accuracy of body coil MR imaging with 
conventional spin-echo sequences was promising [5]. Body coil MR imaging has 
the advantage that pelvic bones and lymph nodes can also be evaluated during the
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same session. However, the signal-to-noise ratio and the spa­
tial resolution are too low to provide high-resoiution images of
the prostate [6].
With the recent development of an endorectal surface coil 
(ERC), the prostate and its surrounding structures are visualized 
much better [7]. With fast spin-echo techniques, T2-weighted 
images in three different planes are obtained in a shorter time 
with a higher resolution matrix and fewer motion artifacts than 
are images obtained with conventional spin-echo sequences 
[8]. The results suggested improved staging accuracy.
Several recent studies have reported the results of MR 
imaging with ERC technique imaging for staging prostate can­
cer [7, 9-16]. Accuracy levels ranged from 54% to 83%. In 
three of these studies, fast spin-echo MR images with an ERC 
were correlated with histopathologic mapping [12,14,16].
As an adjunct to staging, the volume of prostate cancer is 
also important for prognosis [17-19]. When tumor volume is 
smaller than 4 cc metastasis is highly unlikely, whereas when 
tumor volume exceeds 12 cc metastasis is highly likely [20]. 
MR sequences with standard body coil and conventional spin- 
echo techniques have not given accurate images for estimat­
ing tumor volume before surgery [5, 21-25]. However, fast 
spin-echo MR images obtained with a phased-array coil esti­
mated tumor volume better [8].
In our study, we evaluate the diagnostic accuracy of MR 
imaging with fast spin-echo sequences that use an ERC to 
determine tumor presence, tumor volume, and the preopera­
tive stage of prostate carcinoma. In addition, we identify 
common pitfalls of MR imaging interpretation and the corre­
lation of MR images with pathology.
Subjects and Methods
Patient Population
The study population was 34 patients with needle biopsy-proven 
adenocarcinoma. We performed MR imaging that used an ERC tech­
nique and followed that with radical retropubic prostatectomy. 
Patients’ mean age was 65 years old (range, 50-73 years old). When 
biopsies preceded MR imaging, the average time was 3 weeks. 
Patients underwent radical prostatectomy within 3 weeks of imaging. 
Patients who underwent MR imaging and then received hormonal 
treatment before surgery were excluded from this study. All patients 
had clinical T2-3 disease according to the TNM classification (Table 
1) [26]. We detected no lymph-node metastases in frozen sections at 
laparoscopic or open lymph-node dissection that preceded the radical 
prostatectomy. Local staging by MR imaging was correct in 16 of 34 
cases, or 47%, as confirmed by histopathologic examination.
MR Technique
All images were obtained using a 1.5-T Siemens SP system (Sie­
mens, Erlangen, Germany), and a Medrad endorectal coil (Medrad, 
Pittsburgh, PA). We placed the coil with the patient in the lateral 
decubitus position and inflated the coil with 50-100 ml of air. Peri­
stalsis was suppressed by administering 1 mg of glucagon intrave­
nously. A tight band was wrapped around the patient’s abdomen to 
decrease respiratory movement.
A sagittal T1-weighted localized image was obtained to confirm 
coil positioning and to select locations for the axial images. Axial T-1 
weighted images (420/22 [TR/TE]) as well as axial, sagittal, and 
coronal fast spin-echo T2-weighted images (2940/160, echo-train 
length of 13) were performed. All examinations were performed 
using a 4- or 5-mm slice thickness with a 1 - or 2-mm gap, 26-cm 
field of view, and a 512 x 216 matrix. An equalizing processing after 
application and a filter algorithm to compensate for near-field effect 
were also used. We also changed the phase-encoding gradient to 
decrease motion artifacts over the prostate. An examination usually 
lasted 30-45 min.
MR Imaging Examination
The MR images were retrospectively interpreted by a single 
reader, who had been interpreting MR examinations for prostate can­
cer and correlating the results with clinical and pathologic outcome for 
more than 2 years. The reader had no knowledge of the clinical find­
TABLE 1: 1992 Revision of TNM Classification [26]
m  t No-N o . ofDesignation Tumor Characteristics r  " Identified by
Uases MR Imaging
TX Not assessable 0 0
TO Not evident 0 0
T1 Clinically apparent; not palpable or visible by imaging
T1a Found incidentally in 5% or less of tissue resected 0 0
T1b Found incidentally in more than 5% of tissue resected 0 0
T1c Identified by needle biopsy due to elevated serum 
prostate-specific antigen
0 0
T2 Palpable or visible by prostate imaging
T2a Involves half lobe or less 2 0
T2b Involves more than half lobe but not both lobes 0 0
T2c Involves both lobes 20 11
T3 Extends through capsule
T3a Found unilaterally 3 0
T3b Found bilaterally 3 2
T3c Invades seminal vesicles 6 3
T4 Fixed or invades other structures
T4a Invades bladder neck, external sphincter, or rectum 0 0
T4b Invades levator muscles or Is fixed to pelvic wall 0 0
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ings, the PSA level, or the results of histopathologic examination or 
transrectal sonography. Image quality was recorded with special 
regard to motion artifacts. An image was considered to be of poor 
quality when degraded by motion artifacts. Good quality meant that 
these artifacts did not significantly degrade delineation of structures.
On T2-weighted images, an area in the peripheral zone with a 
low signal intensity when compared with the adjacent peripheral 
zone was considered to be a malignancy. Low-signal-intensity areas 
in the central zone were not interpreted as malignancy [27]. If a low- 
signal-intensity area showed high signal on the corresponding T1- 
weighted image, the area was considered to be a hematoma.
Tumors separated by more than 1 cm, without connection to 
another tumor in an adjacent section, were interpreted as separate 
tumor lesions. Tumor volume was calculated by the sum of tumor 
areas multiplied by slice thickness, including gaps between slices.
We used the following criteria to define capsular perforation: dis­
ruption of the prostatic capsule, infiltration of the periprostatic fat, low- 
signal-intensity stranding, and involvement of the neurovascular bun­
dle. A bulge in the contour or capsular thickening was not interpreted 
as capsular perforation [9, 12]. Abnormally low signal intensity within 
the lumen of the seminal vesicle or focal thickening of the seminal 
wall was interpreted as seminal vesicle invasion [9]. Final staging was
recorded accqt'ding to the TNM classification (Table 1) [26].
i
i»
■
Pathologic Examihation
The prostatectomy specimens were in toto fixed overnight in a 
solution of 4% neutral buffered formalin. Step-sections were made at 
4-mm intervals in a plane parallel to the base of the prostate, which 
corresponded to the slices used on MR imaging. After separating the 
step-sections into right and left halves, all sections were routinely 
embedded in paraffin. Tissue sections of 5 |am were prepared and 
stained with hematoxylin and eosin. Regions representing cancer 
were outlined on the glass cover and retraced onto a diagram of the 
axial histologic sections that extended from the base to the apex of 
the prostate. To estimate tumor volume, the sum of the cancer areas 
on all sections was multiplied by 4 mm (slice thickness). The volume 
was then multiplied by a factor of 1.1 to correct for tissue shrinkage 
due to fixation. Length and depth of penetration through the capsule 
and involvement of each seminal vesicle were recorded. Definitive 
staging was performed with the TNM classification [26].
image quality was poor because of motion artifacts caused by 
bowel motion (n = 5) or because of upward migration of the 
endorectal coil (n = 1). Minor image degradation resulted from 
biopsy hematoma, high signal intensity close to the ERC 
(near-field effect), and shallow penetration depth of the ERC; 
however, image quality remained good.
Pitfalls in Correlating MR Images with Histopathologic Findings
The correlation between MR images and tumor maps 
based on histopathology was difficult in almost all patients. 
The most caudal section of MR images was 0.5-1.5 cm lower 
than the section representing the apex in the prostatectomy 
specimen. Also, the angle by which the sections were cut was 
never exactly the same for either technique (difference, 5- 
15°). Furthermore, the shape of the prostate changed after fix­
ation. Also making correlation difficult was the fact that the 
prostate tumors were markedly irregular and often demon­
strated fingerlike projections with ill-defined margins that did 
not display on MR images of 4 or 5 mm (whereas the histo­
logic sections were only 4 jxm thick). We tried to overcome 
these problems by using tumor maps, which gave a good 
three-dimensional picture of the prostate. We also used our 
definition of a matched lesion.
Number and Localization of Tumor Lesions
A total of 44 separate tumor lesions were visualized with MR 
imaging, and 52 were found on histopathologic examination of 
34 patients (mean number of tumors, 1.5; range, 1-3). Thirty- 
four tumors were defined matched lesions (Fig. 1). In 10 false- 
positive lesions identified by MR imaging, histopathology 
showed adjacent cystic changes in six cases. In four other 
false-positive lesions identified by MR imaging, histopathology 
failed to show an explanation for the low signal intensity.
MR imaging correctly depicted the location of 67% of the 
tumors. Twenty-two percent of the lesions depicted by MR 
appeared to be false-positive errors. Fourteen of the 18
Data Analysis
A radiologist and a pathologist analyzed the correlation of MR 
imaging findings and histopathology. The MR images were corre­
lated with tumor maps that were based on the histopathologic sec­
tions. Tumor localization, number of tumors, tumor volume, status of 
the prostate capsule, involvement of each seminal vesicle, and 
definitive stage were evaluated.
To offset the bias of incorrectly identified lesions (false positives), 
we analyzed matched lesions (true positives). A tumor location was 
considered to match if the tumor was present in the same cranio- 
caudal third of the prostate (proximal, mid, or distal) and the tumor 
was localized in the same quadrant, regardless of the size of the 
lesion. Penetration through the capsule was compared for each 
tumor lesion.
Results
The endorectal coil was well tolerated by all patients. In 28 
patients, images obtained with the ERC provided detailed 
visualization of the prostate, prostatic capsule, and peripros­
tatic structures, including the seminal vesicles. In six patients,
uUMipuua m v
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Volume Histopathology (cc)
Fig. 1.—Bar graph shows distribution of lesions determined with his­
topathology (solid bar) ranged in order of actual tumor volume and de­
gree of match lesions (open bar). Tumors less than 2 cc easily remain 
undetected with MR imaging.
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tumors that were missed were located in the central or ventral 
part of the prostate.
Tumor Volume
The accuracy of MR imaging in predicting tumor volume is 
presented in Figure 2.
The mean volume of 44 tumor lesions captured on imaging 
with ERC was 2.3 cc (range, 0.25-11.6 cc). The mean volume 
of 52 histopathologically detected lesions was 1.5 cc (range, 
0.4-7.2 cc). When we compared only matched lesions, the 
mean volume was 2.6 cc by MR imaging with ERC and 1.8 cc 
by histopathology. In seven matched lesions, the tumor vol­
ume estimated by MR imaging fell within a 25% range of the 
actual volume. In 19 other cases, MR imaging overestimated 
the actual tumor volume by more than 25% (Fig. 3), and in 
eight other cases, the underestimation by MR imaging 
exceeded 25%. In the latter group, 50% of the lesions were 
located in the central or ventral part of the prostate.
Capsular Penetration
In 11 of 44 (25%) lesions identified by MR imaging, evidence 
of capsular penetration was stated. In 14 of 52 (27%) lesions 
detected by histopathology, capsular penetration was present.
Fig. 2.—Scatter plot shows poor correlation between volume deter 
mined by MR imaging and actual tumor volume.
False-positive capsular penetration was present in four 
matched and in one false-positive lesion. Three cases of false- 
positive capsular penetration occurred in MR imaging exami­
nations with poor image quality because of motion artifacts.
Histologically, seven patients had capsular penetration 
with a width of more than 5 mm; MR imaging correctly identi­
fied the capsular penetration in four of them. Seven patients 
had capsular penetration with a width of less than 5 mm; MR 
imaging correctly identified two of them. Histologically, capsu­
lar penetration extended less than 1 mm into the periprostatic 
adipose tissue in seven lesions; 1-3 mm in six; and more 
than 3 mm in one (Fig. 4). Sensitivity of MR for depicting cap­
sular penetration into the periprostatic tissue was 14% when 
that penetration was less than 1 mm, 67% when 1-3 mm, 
and 100% when more than 3 mm (Fig. 5).
The capsular bulge sign was not used because it may lead 
to false-positive findings [9]. Capsular bulge was found in four 
cases, once in a true-positive T2 tumor, once in a false-nega- 
tive T3 tumor, and twice in (for other reasons) true-positive T3 
tumors. Thus, this criterion would not change the overall accu­
racy for capsular penetration.
Five patients also had positive surgical margins. However, 
because the surgeon incised the capsule, capsular penetra­
tion could not be evaluated in those sections. Overall figures 
are given in Tables 2 and 3.
11). The results are presented In Tables 4 and 5. The seven 
false-positive seminal vesicles showed no abnormalities in the 
corresponding histopathologic sections. In particular, fibrosis, 
inflammatory infiltrate, amyloid depositions, and blood were 
excluded. Eight vesicles showed focal thickening of the tubular 
wall. Only four of them were true-positive (Figs. 6 and 7).
Staging Prostate Cancer
For all patients, we evaluated final staging of prostate can­
cer by comparing MR images with pathologic appearances 
(Table 1). With the TNM classification, staging was correct in 
15 out of 34 (44%) patients. When staging was limited to 
depict locally advanced disease, (>T3, formerly Jewitt stage 
C) sensitivity, specificity, accuracy, and positive predictive 
values of MR staging were 67%, 68%, 68%, and 53%, 
respectively (Table 6).
One patient who had stage pT3b (bilateral capsular pene­
tration) disease was staged with MR imaging as mT3c with­
out capsular perforation. Another patient was correctly 
staged as mT3 because of a false-positive and a false-nega­
tive lesion; thus, staging by MR imaging in these patients 
was correct for an incorrect reason.
In vasion of Seminal Vesicles
All 68 seminal vesicles were visualized. MR imaging showed 
tumor invasion in 11 seminal vesicles of eight patients, of which 
four lesions were confirmed on histopathology. In 51 out of 57 
seminal vesicles, invasion was correctly excluded with MR 
imaging. The sensitivity was 36% (4 of 11). The specificity was 
89% (51 of 57). The positive predictive value was 36% (4 of
Discussion
Motion artifacts were the primary cause of low-quality 
images in five examinations (14%). Also, of these five cases, 
three had false-positive capsular penetration. Little is 
reported in the literature about significant motion artifacts 
and the use of ERC. However, with fast spin-echo imaging 
and a pelvic phased-array multicoil, one study reported sig-
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Fig. 3.—Overestimating of tumor volume and 
underestimating of number of tumors in 62- 
year-old man,
A, Axial fast-spin-echo T2-weighted image 
shows zone of decreased intensity on right 
(arrows), interpreted as carcinoma. Estimated 
volume was 3.3 cc. At pathologic examination, 
tumor location was almost symmetrically bilat­
eral. Calculated tumor volume both right and 
left was 0.7 cc.
B, Photograph of histopathologic section 
shows two small tumor foci (arrows) on right side.
1 .1 J  *r <
" - Í Ú  . .  j
A B
Fig. 4.—Good correlation between MR imag­
ing and pathology in 57-year-old patient
A, Axial T2-weighted fast spin-echo image 
shows gross extracapsular tumoral involve­
ment of extraprostatic tissue (arrows).
B, Photograph of pathologic specimen 
shows close match for status of capsule and tu­
mor volume (arrows).
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nificant motion artifacts in up to 45% of examinations when 
glucagon was not used versus 7% with glucagon [8].
Number and Localization
In our study, correlation was good between number and 
localization of tumors. The positive predictive value and sensi­
tivity level were relatively high, comparable to that of other 
studies [12,14, 25, 28]. We confirmed that tumors located ven- 
trally and centrally on histopathologic examination are pitfalls 
for false-negative tumors. Carter et al. [28] found a sensitivity 
of 15% in detecting anterior tumors, a percentage considerably 
lower than they achieved in detecting posterior tumors (85%). 
Outwater et al. [12] did not identify any of 29 central gland 
tumors and 41 of 56 (73%) peripheral tumors on MR imaging 
that used an ERC technique.
Causes for false-positive findings that are reported in the lit­
erature include hyperplasia, prostatitis, postbiopsy hemor­
rhage with blood in the extracellular methemoglobin state, 
and areas of cystic change [25]. Cystic change increases the 
signal intensity of the peripheral zone, resulting in a relatively 
low signal intensity compared with adjacent areas of normal 
prostate, which may be confused with malignant lesions. We
found neither histologic evidence of hematoma nor other 
pathologic changes in areas defined as hematoma on T1- 
weighted images. These findings concur with a study in which 
27 false-positive lesions that corresponded with areas of hem­
orrhage on T1-weighted images did not show any pathologic 
substrate, especially no evidence of hemorrhage [14]. Also, 
the pathologist cited by Tempany et al. [16] stated that the 
effects of hemorrhage and biopsy are difficult to quantify and 
cannot always be identified at pathologic analysis.
Tumor Volume
Tumor volume is a known predictor of pathologic stage 
[17]. With a tumor volume larger than 12 cc, extraprostatic 
spread of disease has likely occurred, whereas tumors 
smaller than 4 cc are usually locally confined [20]. Tumor 
volume is reported to correlate more closely with progres­
sion than with capsular penetration [19].
We found a poor correlation between tumor volumes calcu­
lated from MR images and those found at pathologic exami­
nation. Although pathologic examination frequently showed 
tumor extension into the central and ventral part of the pros­
tate, MR images overestimated mean volume in all lesions
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Fig. 5.—Bar graph shows relation of detecting capsular penetration 
with MR imaging (open bar), to depth of tumor invasion (mm) on histopa- 
thology (solid bar). Sensitivity was 14%, 67%, and 100% for capsular pen­
etration of less than 1 mm, between 1 and 3 mm, and more than 3 mm, 
respectively.
TABLE 2: Results of MR Imaging for Capsular Penetration with 
Ail Histologic Lesions
MR Findings
Present
Histopathology
Absent Total
Present
Absent
Total
6
8
5
33
11
41
14 38 52
Note,—Sensitivity = 42%; specificity = 87%; accuracy = 75%; positive pre­
dictive value = 55%.
TABLE 3: Results of MR Imaging for Capsular Penetration with 
Matched Lesions
MR Findings
Histopathology
"N»!'
Present Absent Total
Present
Absent
Total
6
5
4
19
10
24
1 4  » Ail
11 23 34
and in matched lesions. We could not identify any reasons for 
this overestimate of tumor volume by MR imaging.
Studies performed with MR imaging using body coils 
reported a poor correlation between tumor volume as 
depicted on MR imaging and the volume calculated from the 
pathologic specimen [5, 21, 22, 24]. No studies in the litera­
ture used an ERC, although one study was performed with 
an external array coil and fast spin-echo technique [25]. This 
study reported a significant correlation between tumor vol­
ume calculated with MR images and that of the pathological 
specimen (r= .81, p < .001), but accuracy was not enough to 
be helpful in making clinical decisions.
To meet the problems of low predictive values for detecting 
tumors and estimating their volumes, studies have been per­
formed that evaluated IV contrast medium-enhanced T1- 
weighted images [11, 29]. However, improvement over T2- 
weighted FSE images was not observed. Nonetheless, the 
report of one study that used dynamic, single-slice T1- 
weighted technique after IV contrast medium with a high-time 
resolution (one image/sec) suggests that a better delineation 
of prostate cancer detection, volume, and staging may be 
possible with MR imaging [30].
Note.—Sensitivity = 55%; specificity = 85%; accuracy = 74%; positive pre 
dictive value = 60%.
Capsular Penetration
Accuracy for capsular penetration in our study was low for 
matched lesions (55%) because capsular penetration was 
less than 3 mm in all but one case. On matched lesions we 
found no relation between the width or length of the capsule 
at pathologic examination and the staging accuracy with MR 
imaging. Five patients with positive surgical margins due to 
incision by the surgeon through the capsule were classified 
as T2 because penetration through the prostatic capsule 
could not be confirmed. Of these five, MR classification was 
T2 in three cases and T3 in two cases.
In a recent overview, Schiebler et al. [31] stated that body 
coil MR imaging proves unsatisfactory at detecting capsular
penetration due to the limited spatial resolution of the imaging 
technique. MR imaging that uses ERC technique is reported 
to more reliably identify the prostatic capsule [15]. Detection of 
capsular penetration with MR imaging with ERC technique 
had a sensitivity of 67% compared with body coil MR imaging, 
which had a sensitivity of 44% in the same patient cohort. 
However, the results of recent studies of MR imaging with 
ERC technique showed limited accuracy for detecting capsu­
lar penetration [9, 12, 14, 16]. For example, Tempany et al. 
[16] reported that accuracy rates of MR imaging with ERC 
technique for detecting capsular penetration from different 
institutions ranged from 33% to 54%, which is less accurate 
than conventional body-coil MR imaging.
These conflicting findings may result from the lack of 
highly specific and sensitive diagnostic criteria for capsular 
penetration. One study has evaluated six different diagnostic 
criteria for capsular penetration [12]. The positive predictive 
value of each individual sign ranged from a minimum of 4% 
for capsular thickening to a maximum of 34% for extracapsu- 
lar tumor.
It should be noted that focal penetration probably has a prog­
nosis comparable to T2 tumors [3]. Therefore, only identifica­
tion of deeper penetration may be of clinical importance [32].
Seminal Vesicle Invasion
The accuracy for detecting seminal vesicle involvement in 
our series agreed with that in other series. A high specificity 
(85-97%) and a low sensitivity (21-63%) [9, 14, 16] were 
reported. In our study, the figures were 82% and 50%, 
respectively. Although we could not explain the false-positive 
findings in the histopathology, low signal intensity of the 
seminal vesicles on T2-weighted images can be caused by 
amyloid deposits [33] or seminal vesicles that contain stones
AJR:166, April 1996 STAGING OF PROSTATE CANCER WITH MR IMAGING 851
TABLE 4: Results of MR Imaging for Seminal Vesical Invasion
Histopathology
MR F in d in g s .......................................................... .....-..—-
Present Absent Total
Present 4 7 11
Absent 7 51 58
Total TÏ 58 ~  69
Note.—Sensitivity = 36%; specificity = 89%; accuracy = 79%; positive pre­
dictive value = 36%.
TABLE 6: Results of Detecting Extraprostatic Disease (>T3)
Histopathology
MR Findings --------------------------- --------- -— -—------- - ----------
p< 12 p> T3 Total
,  ■ n »  ■ ^ . , . 1 » ^ * . .  * ...........- » - - I - ,* - . ----------------------------------  -  “ ................... r ------------- --- --------------------- . . . .  .  . . .  .  - I- I--T----- , -----------  -------  , - ----  , - • • - I I - - - 1 I I I M M I  | | t | - ‘  ■ D i n i l ■ ‘ " ¥ » ‘f i 1 t »i» . f c h t f f l T  ~ M ip »  l . l l l l l  I --------I ■ I I »  I 1  I ‘  |  U j l  1 i» i I » * . 111 M lf l . )< nj ‘
m^T2  15 4 19
m > T3 7 8 15
- w( “ “ " «• ■ 1 .............n Ji 1 ■ «■ tias.i i- -  ........ -p niii---- • a n---------- i i ■ ■ -i -•<- .-■ i w ■ t
Total 22 12 34
Note.—Sensitivity >T3 = 67%; specificity ST3 = 68%; accuracy = 68%; neg­
ative predictive value &T3 = 79%; positive predictive value ST3 = 53%.
TABLE 5: Results of MR Imaging for Seminal Vesical Invasion 
for Each Patient
MR Findings
Histopathology
n*s^mrr»i«uw * . i*. j t  <•*r.
Present Absent Total
- i ‘iiwri'fi - -1 ~ w M ■ iMiBi ■ é  *  VL^4. AVvr t r * ■ *i «Vi
Present
Absent
Total
3
6
5
20
8
26
9 25 34
The patient group in our study was limited to the patients 
who underwent radical prostatectomy. We also perform MR 
imaging on the prostates of patients who did not undergo 
radical prostatectomy because of positive lymph nodes or 
because of the overall staging results. The accuracy rate 
might well be different if this group were also included.
Note.—Sensitivity = 33%; specificity = 80%; accuracy = 68%; positive pre­
dictive value = 38%.
Difficulties in Evaluating the Literature
The continuous, rapid technical development of image
sequences and coil design such as pelvic phased-array and
integrated endorectal pelvic phased-array coils [34] can pro- 
or blood [31]. Focal tubular thickening proved unreliable in dUCe a wide divergence of image quality. Imaging with the
predicting seminal vesicle involvement in our series. combination of an ERC and a phased-array multicoil is now
advocated as the most powerful tool.
In addition, a broad spectrum of diagnostic signs (often indi­
rect) and differently defined criteria for capsular penetration 
make metaanalysis of the literature difficult. For example, 
authors of one report changed image sequences, surface coils, 
and diagnostic criteria during the study [14]. Also, not all reports 
are blinded in the same way. Accuracy levels may be pushed 
higher when clinical data (prostate-specific antigen, prior histo­
ries of prostatitis, and locations of the positive biopsy findings) 
are integrated with interpretation of the images as recom­
mended by Schiebler et al. [31]. Furthermore, it is often difficult 
to assess the extent to which information gained from MR 
imaging was used in patient management (verification bias) 
[36, 37]. In our institution, the prevalence of T3 tumors at opera-
Overall Staging
In our study, staging according to the TNM classification 
was correct in 47% of the patients. Accuracy for differentiating 
a T2 from a T3 tumor was 68%. Except for Hricak et al. [34], 
other studies restricted staging to differentiating T2 from T3. 
The first series on imaging with an ERC reported an 82% 
accuracy rate, which was a 16% improvement over body coil 
staging with the same cohort of patients [15]. Recent series 
reported an overall accuracy of 54-68% for MR imaging that 
used an ERC [9, 12, 14, 16]. Accuracy in prospective studies 
(51%) is considerable lower than in retrospective studies 
(67%) [14, 35].
Fig. 6.—Axial T2-weighted fast spin-echo Im­
age of 67-year-old patient shows thickening of 
wall of seminal vesicles {arrows). Seminal vesi­
cle invasion was confirmed at pathologic exam­
ination.
Fig. 7.— Axial T2-welghted fast-spin-echo im­
age of 63-year-old patient shows more pro­
nounced tubular thickening (arrows), but 
seminal vesicle invasion was not present at 
pathologic examination.
. . : . ' : ; r : vi ;Y £Ÿr.’ : : > r 'Ìv^ À
r .r \
um >o•.* J,r-Mvfe'i
Ir;/,V- * i  i  •. •( .  / .  »«
- '•v * Ï'V.
• Vii «¿a
ïW-?.
m
• 'W
m-. ÿ-ï'ev
•■m.
1*11
S0.C-
n  * . . . .
mm
m m .  
m m  
'■ m
i»; M ».0Mß
• 'SX1; i t iVX'/.
si?
i---;
ill
; 5'-'/Vi»fr
6 7
852 JAGER ET AL AJR:166, April 1996
tion has decreased from 63% in the study by Jager et al. [10] to 
35% in this study. Because prostate cancer often leads to sur­
gery at an early stage [38], correction for verification bias 
remains impossible. For these reasons, comparison of our pre­
sented figures to those of other studies is difficult.
Conclusion
Although MR imaging using an ERC with a fast spin echo 
was not highly accurate in predicting definitive tumor volume or 
definitive stage, the technique may prove helpful when selecting 
patients for definitive therapy because small capsular penetra­
tion of less than 1 mm—often not detected by MR imaging— 
does not rule out radical prostatectomy. Follow-up studies are 
necessary to evaluate the effect of understaging minimal capsu­
lar penetration. In our series, overstaging occurred frequently in 
cases with low-quality images due, at least in part, to motion arti­
facts. Because tumor volume is likely to be more important than 
focal capsular penetration, the accuracy of assessing tumor vol­
ume must improve. Dynamic, single-slice T1 -weighted tech­
nique that uses an IV contrast medium with high-time resolution 
(1 image/sec) shows promise of improved accuracy [30].
Because the value of MR imaging is not yet established 
and because the results of studies are difficult to compare, 
we conclude that those who perform MR imaging in cases of 
prostate cancer should determine their own standard of 
accuracy by carefully comparing their imaging results with 
histopathologic findings.
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